On home turf, sentiment was hit by the Reserve Bank pegging GDP growth for the current fiscal lower at 7.3 per cent and saying that rush for farm loan waivers may have inflationary spillovers, brokers saId.
The 30-share index resumed higher at 31,316.91 and hovered in a range of 31,354.51 and 31,193.77 before settling at 31,213.36, showing a loss of 57.92 points, or 0.19 per cent.
The NSE 50-share Nifty also down 16.65 points, or 0.17 per cent, to 9,647.25, after shuttling between 9,688.70 and 9,641.50.
"With RBI decision past, markets looked to have retracted into a shell, awaiting further sparks. While UK election and ECB meet added to the restraint, pharma space saw buying after the recent falls attracted bargain buyers. Investors will now look forward to emerging confidence among industry participants as GST rollout approaches," Anand James, Chief Market Strategist, Geojit Financial Services Ltd said.
Investors remained focused on the critical UK general election in which voting is getting underway along with the European Central Bank's policy meeting and congressional testimony from ex-FBI director James Comey.
Oil and gas suffered the most by falling 1.38 per cent, followed by IT 1.33 per cent, teck 1.19 per cent, PSU 0.60 per cent, consumer durables 0.58 per cent, capital goods 0.36 per cent, realty 0.21 per cent, FMCG 0.19 per cent and banking 0.15 per cent.
Other laggards were GAIL, HeroMotoCorp, Asian Paints, ICICI Bank, Bharti Airtel, M&M, Hind Unilver, ONGC, L&T, Reliance Industries, SBI, Coal India, ITC Ltd and Adani Ports, falling by up to 3.44 per cent.
However, pharma stocks such as Dr Reddy, Sun Pharma and Cipla attracted fresh buying, gaining up to Rs 3.79 per cent and cushioned the fall.
The broader market outperformed the key indices with the small-cap index rising 0.30 per cent and the mid-cap index rose 0.23 per cent after investors widened their portfolios.
Stock markets in Germany, France and UK were up in early trade.
Meanwhile, Foreign portfolio investors (FPIs) bought shares worth a net Rs 73.79 crore, while domestic institutional investors (DIIs) had also bought shares worth a net Rs 166.22 crore yesterday as per provisional data.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
